Latest News & Features
Big Pharma
Crowell & Moring has welcomed Gunther Meyer, who previously led the Brussels IP group at Eversheds Sutherland, as a senior counsel in the firm’s IP group. 2 October 2018
Europe
BIO-Europe heads to Scandinavia for the first time, as Copenhagen plays host in November. LSIPR finds out more. 2 October 2018
Asia
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China. 1 October 2018
Americas
Teva has once again taken Eli Lilly to court over a migraine drug, just hours after Eli Lilly’s gained Food and Drug Administration approval to market Emgality. 1 October 2018
Americas
US-based Alexion Pharmaceuticals has announced its plan to acquire Syntimmune, a clinical-stage biotechnology company. 1 October 2018
article
The issue of inefficiencies in the life sciences IP market is a hot topic to be discussed at the Life Science IP Forum in London in November, as LSIPR finds out. 1 October 2018
article
US company KSQ Therapeutics, a specialist in using CRISPR for drug development, has raised $80 million in series C funding. 28 September 2018
Americas
A Brazilian federal judge has granted a preliminary injunction against a patent for US-based Gilead’s Sovaldi drug, used to treat hepatitis C, following a complaint by a presidential candidate. 27 September 2018
Americas
While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out. 27 September 2018
Americas
Gilead is set to produce cheaper authorised generic versions of its branded hepatitis C treatments from 2019. 26 September 2018